SG Americas Securities LLC Sells 14,359 Shares of Innospec Inc. (NASDAQ:IOSP)

SG Americas Securities LLC lowered its position in Innospec Inc. (NASDAQ:IOSPFree Report) by 72.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,413 shares of the specialty chemicals company’s stock after selling 14,359 shares during the period. SG Americas Securities LLC’s holdings in Innospec were worth $667,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. increased its stake in shares of Innospec by 7.4% during the 1st quarter. JPMorgan Chase & Co. now owns 104,796 shares of the specialty chemicals company’s stock worth $9,699,000 after purchasing an additional 7,181 shares during the last quarter. Bank of New York Mellon Corp increased its position in Innospec by 1.9% during the first quarter. Bank of New York Mellon Corp now owns 305,809 shares of the specialty chemicals company’s stock worth $28,302,000 after buying an additional 5,638 shares during the last quarter. American Century Companies Inc. raised its holdings in Innospec by 20.3% during the first quarter. American Century Companies Inc. now owns 5,934 shares of the specialty chemicals company’s stock valued at $549,000 after buying an additional 1,002 shares in the last quarter. Citigroup Inc. lifted its position in shares of Innospec by 11.9% in the first quarter. Citigroup Inc. now owns 21,356 shares of the specialty chemicals company’s stock worth $1,976,000 after buying an additional 2,264 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Innospec by 8.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,783 shares of the specialty chemicals company’s stock worth $165,000 after acquiring an additional 141 shares in the last quarter. Institutional investors own 96.64% of the company’s stock.

Innospec Stock Performance

Shares of NASDAQ IOSP opened at $125.75 on Thursday. The business’s 50-day simple moving average is $123.01 and its 200-day simple moving average is $113.54. Innospec Inc. has a 52 week low of $91.74 and a 52 week high of $131.18. The firm has a market cap of $3.14 billion, a price-to-earnings ratio of 22.58 and a beta of 1.10.

Innospec (NASDAQ:IOSPGet Free Report) last announced its quarterly earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.59 by $0.25. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The company had revenue of $494.70 million for the quarter, compared to the consensus estimate of $479.47 million. During the same quarter last year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was down 3.1% compared to the same quarter last year. As a group, equities research analysts forecast that Innospec Inc. will post 6.72 earnings per share for the current year.

Insider Activity at Innospec

In other Innospec news, SVP David B. Jones sold 2,500 shares of the company’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $125.79, for a total transaction of $314,475.00. Following the completion of the sale, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Innospec news, CFO Ian Cleminson sold 931 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $124.07, for a total value of $115,509.17. Following the sale, the chief financial officer now owns 22,996 shares of the company’s stock, valued at approximately $2,853,113.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP David B. Jones sold 2,500 shares of Innospec stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $125.79, for a total value of $314,475.00. Following the completion of the transaction, the senior vice president now directly owns 9,664 shares in the company, valued at $1,215,634.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 36,500 shares of company stock worth $4,532,959. 1.35% of the stock is owned by insiders.

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Recommended Stories

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.